Header
Header
Article

New patent expiration for Collegium Pharm drug NUCYNTA ER – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published at New patent expiration for Collegium Pharm drug NUCYNTA ER


Annual Drug Patent Expirations for NUCYNTA+ER

Nucynta Er is a drug marketed by Collegium Pharm Inc and is included in one NDA. It is available from two suppliers. There are eight patents protecting this drug and one Paragraph IV challenge.

NUCYNTA ER drug price trends.

Drug patent litigation for NUCYNTA ER.

This drug has two hundred and sixty-nine patent family members in thirty-seven countries.

The generic ingredient in NUCYNTA ER is tapentadol hydrochloride. Two suppliers are listed for this compound. Additional details are available on the tapentadol hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for Collegium Pharm drug NUCYNTA ER



Source link

Back to top button